SYN-010

· Theriva Biologics, Inc.

Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for SYN-010, covering 2017-03-08 to 2021-09-05. Get the full timeline:

Most recent: Clinical Trial Update: Efficacy and Safety of SYN-010 in IBS-C [Phase 2]